Phase Ib/II Trial of Combining Pembrolizumab and Lenvatinib With SBRT for HCC Patients With Portal Vein Thrombosis.

Name: Phase Ib/II Trial of Combining Pembrolizumab and Lenvatinib With SBRT for HCC Patients With Portal Vein Thrombosis.
License: Public Domain

National Taiwan University Hospital

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

pembrolizumab

unresectable hepatocellular carcinoma, pembrolizumab, lenvatinib, stereotactic body radiotherapy

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 261490
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.